Renovorx announces presentation at symposium on clinical interventional oncology highlighting tamp™ for targeted treatment of locally advanced pancreatic cancer

Published data shows that chemotherapy delivered via tamp with prior chemoradiation in locally advanced pancreatic cancer observed an overall survival of 27-months published data shows that chemotherapy delivered via tamp with prior chemoradiation in locally advanced pancreatic cancer observed an overall survival of 27-months
RNXT Ratings Summary
RNXT Quant Ranking